Implications of reactive oxygen species in lung cancer and exploiting it for therapeutic interventions

Lung cancer is the second (11.4%) most commonly diagnosed cancer and the first (18%) to cause cancer-related deaths worldwide. The incidence of lung cancer varies significantly among men, women, and high and low-middle-income countries. Air pollution, inhalable agents, and tobacco smoking are a few...

Full description

Saved in:

Bibliographic Details
Published in:	Medical oncology (Northwood, London, England) Vol. 40; no. 1; p. 43
Main Authors:	ArulJothi, K. N., Kumaran, K., Senthil, Sowmya, Nidhu, A. B., Munaff, Nashita, Janitri, V. B., Kirubakaran, Rangasamy, Singh, Sachin Kumar, Gupt, Gaurav, Dua, Kamal, Krishnan, Anand
Format:	Journal Article
Language:	English
Published:	New York Springer US 06-12-2022 Springer Nature B.V
Subjects:	Apoptosis Cell cycle Cell death Female Hematology Humans Internal Medicine Lung cancer Lung Neoplasms - drug therapy Medicine Medicine & Public Health Oncology Oxidative stress Pathology Reactive Oxygen Species Review Review Article Oxidative stress Reactive oxygen species Programmed cell death Cancer therapy Lung cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Lung cancer is the second (11.4%) most commonly diagnosed cancer and the first (18%) to cause cancer-related deaths worldwide. The incidence of lung cancer varies significantly among men, women, and high and low-middle-income countries. Air pollution, inhalable agents, and tobacco smoking are a few of the critical factors that determine lung cancer incidence and mortality worldwide. Reactive oxygen species are known factors of lung carcinogenesis resulting from the xenobiotics and their mechanistic paths are under critical investigation. Reactive oxygen species exhibit dual roles in cells, as a tumorigenic and anti-proliferative factor, depending on spatiotemporal context. During the precancerous state, ROS promotes cancer origination through oxidative stress and base-pair substitution mutations in pro-oncogenes and tumor suppressor genes. At later stages of tumor progression, they help the cancer cells in invasion, and metastases by activating the NF-kB and MAPK pathways. However, at advanced stages, when ROS exceeds the threshold, it promotes cell cycle arrest and induces apoptosis in cancer cells. ROS activates extrinsic apoptosis through death receptors and intrinsic apoptosis through mitochondrial pathways. Moreover, ROS upregulates the expression of beclin-1 which is a critical component to initiate autophagy, another form of programmed cell death. ROS is additionally involved in an intermediatory step in necroptosis, which catalyzes and accelerates this form of cell death. Various therapeutic interventions have been attempted to exploit this cytotoxic potential of ROS to treat different cancers. Growing body of evidence suggests that ROS is also associated with chemoresistance and cancer cell immunity. Considering the multiple roles of ROS, this review highlights the exploitation of ROS for various therapeutic interventions. However, there are still gaps in the literature on the dual roles of ROS and the involvement of ROS in cancer cell immunity and therapy resistance.
ISSN:	1559-131X 1357-0560 1559-131X
DOI:	10.1007/s12032-022-01900-y